Miniatura

Fitxers

s12933-021-01261-2.pdf (924.53 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-03-23

Llicència de publicació

cc by (c) Moreno et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176046

Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/s12933-021-01261-2

Resum

Background: During COVID-19 pandemic, elective invasive cardiac procedures (ICP) have been frequently cancelled or postponed. Consequences may be more evident in patients with diabetes. Objectives: The objective was to identify the peculiarities of patients with DM among those in whom ICP were cancelled or postponed due to the COVID-19 pandemic, as well as to identify subgroups in which the influence of DM has higher impact on the clinical outcome. Methods: We included 2,158 patients in whom an elective ICP was cancelled or postponed during COVID-19 pandemic in 37 hospitals in Spain. Among them, 700 (32.4%) were diabetics. Patients with and without diabetes were compared. Results: Patients with diabetes were older and had a higher prevalence of other cardiovascular risk factors, previous cardiovascular history and co-morbidities. Diabetics had a higher mortality (3.0% vs. 1.0%; p = 0.001) and cardiovascular mortality (1.9% vs. 0.4%; p = 0.001). Differences were especially important in patients with valvular heart disease (mortality 6.9% vs 1.7% [p < 0.001] and cardiovascular mortality 4.9% vs 0.9% [p = 0.002] in patients with and without diabetes, respectively). In the multivariable analysis, diabetes remained as an independent risk factor both for overall and cardiovascular mortality. No significant interaction was found with other clinical variables. Conclusion: Among patients in whom an elective invasive cardiac procedure is cancelled or postponed during COVID-19 pandemic, mortality and cardiovascular mortality is higher in patients with diabetes, irrespectively on other clinical conditions. These procedures should not be cancelled in patients with diabetes.

Matèries

Diabetis, COVID-19, Cardiologia, Mortalitat

Matèries (anglès)

Diabetes, COVID-19, Cardiology, Mortality

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MORENO, Raúl, DÍEZ GIL, José luís, DIARTE, José antonio, SALINAS, Pablo, TORRE HERNÁNDEZ, José maría de la, ANDRES CORDÓN, Juan f., TRILLO, Ramiro, ALONSO BRIALES, Juan, AMAT SANTOS, Ignacio j., ROMAGUERA, Rafael, DÍAZ, José francisco, VAQUERIZO, Beatriz, OJEDA, Soledad, CRUZ GONZÁLEZ, Ignacio, MORENA SALAS, Daniel, PÉREZ DE PRADO, Armando, SARNAGO, Fernando, PORTERO, Pilar, GUTIERREZ BARRIOS, Alejandro, ALFONSO, Fernando, BOSCH, Eduard, PINAR, Eduardo, RUIZ ARROYO, José ramón, RUIZ QUEVEDO, Valeriano, JIMÉNEZ MAZUECOS, Jesús, LOZANO, Fernando, RUMOROSO, José ramón, NOVO, Enrique, IRAZUSTA, Francisco j., GARCÍA DEL BLANCO, Bruno, MOREU, José, BALLESTEROS PRADAS, Sara m., FRUTOS, Araceli, VILLA, Manuel, ALEGRÍA BARRERO, Eduardo, LÁZARO, Rosa, PAREDES, Emilio. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic. _Cardiovascular Diabetology_. 2021. Vol. 20. [consulta: 25 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/176046]

Exportar metadades

JSON - METS

Compartir registre